Representative Gus Bilirakis (R-FL) has introduced a bipartisan, bicameral bill to improve access to molecular diagnostic ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...

Effortlessly extract high-quality cfDNA with automated, next-generation sequencing-ready solutions tailored for neonatal ...

Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems ... Rapid molecular diagnostics are crucial, as imatinib-sensitive fusions ...

The "Genomic Reference Materials and Controls Systems Market: Focus on Product Type, Application, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ...

A new approach to monitoring molecular processes deep in tissues could accelerate personalized medicine, cancer diagnostics ...

The journal Advanced Materials recently published a study introducing a new method for monitoring molecular processes deep ...

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet ...

SUNNYVALE, Calif., Oct. 27, 2016 /PRNewswire/ -- With the flu season fast approaching, healthcare providers no longer need to choose between a fast test result or an accurate test result for ...

The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8%. The global point-of-care (POC) diagnostics market is ...

The machine learning-driven model analyses gut and oral microbiome functions to determine biological aging in comparison to ...

US official says Trump confident China will not invade Taiwan during his term The isothermal nucleic acid amplification technology market has evolved significantly due to the growing need for ...